Centiva Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Centiva Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.7M	Buy	99,500 +29,500	+42%	+$3.68M	0.09%	145
2025 Q4	$8.54M	Buy	70,000 +50,000	+250%	+$5.73M	0.07%	183
2025 Q3	$2M	Sell	20,000 -80,000	-80%	-$7.21M	0.02%	382
2025 Q2	$8.29M	Buy	+100,000	New	+$7.98M	0.14%	99
2025 Q1	–	Sell	-200	Closed	-$18K	–	2210
2024 Q4	$18K	Sell	200 -200	-50%	-$19.4K	﹤0.01%	1567
2024 Q3	$39.5K	Sell	400 -23,200	-98%	-$2.28M	﹤0.01%	2012
2024 Q2	$2.19M	Buy	23,600 +20,400	+638%	+$1.83M	0.04%	373
2024 Q1	$304K	Sell	3,200 -43,000	-93%	-$3.99M	0.01%	1241
2023 Q4	$4.13M	Buy	46,200 +26,200	+131%	+$1.95M	0.1%	198
2023 Q3	$1.46M	Buy	20,000 +10,000	+100%	+$799K	0.03%	493
2023 Q2	$832K	Buy	+10,000	New	+$836K	0.02%	636
2022 Q3	–	Sell	-25,000	Closed	-$1.86M	–	1841
2022 Q2	$1.86M	Buy	+25,000	New	+$1.88M	0.04%	379
2020 Q4	–	Sell	-4,300	Closed	-$479K	–	1128
2020 Q3	$479K	Sell	4,300 -1,300	-23%	-$146K	0.03%	362
2020 Q2	$627K	Sell	5,600 -4,200	-43%	-$414K	0.04%	247
2020 Q1	$759K	Sell	9,800 -4,000	-29%	-$354K	0.03%	261
2019 Q4	$1.32M	Buy	13,800 +9,800	+245%	+$848K	0.06%	256
2019 Q3	$305K	Hold	4,000	–	–	0.02%	435
2019 Q2	$352K	Hold	4,000	–	–	0.02%	286
2019 Q1	$360K	Buy	+4,000	New	+$340K	0.02%	245

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Centiva Capital's XBI Position: Q3 2024 in Review

Centiva Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 4,659 shares — an estimated $458K sold.

Centiva Capital first reported a position in XBI in Q1 2019 and held it in 7 quarters. The position peaked at $4.81M in Q4 2023. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

Centiva Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
Centiva Capital sold 4,659 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $458K.
Centiva Capital first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 7 quarters.
Centiva Capital's State Street SPDR S&P Biotech ETF position peaked at $4.81M in Q4 2023.
769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Centiva Capital's 13F filing for Q3 2024, filed 14 Nov 2024.